Guru Nanak Eye Clinic Delhi offers optometrist training

Published Date: 17 Feb 2023

Delhi: Guru Nanak Eye Care Center in Delhi offers B Optom course. Guru Nanak Eye Care Center is the best...

Read Full News

Latest News

Medical Bulletin 09/December 2023.

The most important medical news of the day is as follows: early age at first menstrual cycle associated with increased risk of diabetes in middle age.

To advance space and high altitude medicine, AIIMS Delhi and AFMS collaborate.

New Delhi: A memorandum of understanding (MOU) will be signed by the Directorate General of the All India Institute of Medical Sciences (AIIMS) in New Delhi.

A study found that elderly people with poorer diet quality may benefit cognitively from taking a cocoa extract supplement.

USA: A new study on the impact of supplementing with cocoa extract on cognition was published in The American Journal of Clinical Nutrition.

Delhi High Court criticizes the Delhi Medical Council, asserting that the public has a right to know whether or not a person identifying themselves as an MD is in fact in possession of that degree.

New Delhi: In contemplation of filing a Public Interest Litigation (PIL) to obtain a deadline-bound verification of medical and educational credentials.

A strange link between owning cats and schizophrenia has been found in a study.

Cats are wonderful pets, and they can be enjoyed in both large and small homes. However, a recent review indicates that owning a cat may not be the best idea.

In the Philippines, relief for FMGs: NMC grants course recognition to students who were enrolled in BS courses prior to the implementation of FMGL regulations.

The declaration by the National Medical Commission (NMC) that students who were foreign medical students in the Philippines are truly relieved.

Todays Updates

This Week on NeurologyLive® — November 24, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Positive Phase 3 OCEANIC-STROKE Data Position Asundexian for Upcoming FDA Submission Marco Meglio

Encouraging data from the OCEANIC-STROKE study suggest that asundexian may soon join the therapeutic landscape for secondary stroke prevention as Bayer advances toward submission.

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Benjamin Locksin speaks in this interview about his session titled ‘Encapsulating Progress With New and Emerging TYK2 Inhibitors for Psoriasis.’

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Todays Updates

This Week on NeurologyLive® — November 24, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Positive Phase 3 OCEANIC-STROKE Data Position Asundexian for Upcoming FDA Submission Marco Meglio

Encouraging data from the OCEANIC-STROKE study suggest that asundexian may soon join the therapeutic landscape for secondary stroke prevention as Bayer advances toward submission.

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Benjamin Locksin speaks in this interview about his session titled ‘Encapsulating Progress With New and Emerging TYK2 Inhibitors for Psoriasis.’

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Latest News

The most important medical news of the day is as follows: early age at first menstrual cycle associated with increased risk of diabetes in middle age.

New Delhi: A memorandum of understanding (MOU) will be signed by the Directorate General of the All India Institute of Medical Sciences (AIIMS) in New Delhi.

USA: A new study on the impact of supplementing with cocoa extract on cognition was published in The American Journal of Clinical Nutrition.

New Delhi: In contemplation of filing a Public Interest Litigation (PIL) to obtain a deadline-bound verification of medical and educational credentials.

Cats are wonderful pets, and they can be enjoyed in both large and small homes. However, a recent review indicates that owning a cat may not be the best idea.

The declaration by the National Medical Commission (NMC) that students who were foreign medical students in the Philippines are truly relieved.

News All Time

Delhi High Court: MCI sanctions cannot be used as a yardstick for determining a doctor's shortcomings, flaws, or insufficiency.

New Delhi: The Delhi High Court recently declared that the punishment awarded by the MCI, which is now the National Medical Commission (NMC), could not be an.

Eugene A. Woods joins the board of directors at JnJ.

Johnson and Johnson has announced in New Brunswick that Eugene A. The new CEO of Advocate Health is Woods, MBA, MHA.

As per JAMA, Prone Positioning Has No Effect on the Length of ECMO Weaning in Covid Patients with Severe ARDS.

According to Matthieu Schmidt and colleagues, a randomized clinical trial examined the effects of prone positioning on patients suffering from severe acute respiratory distress.

Rituximab and glucocorticoids in Wegener's Granulomatosis: A PMS Study Report approved by the CDSCO Panel.

New Delhi: The Central Drug Standard Control Organization (CDSCO)'s Subject Expert Committee (SEC) has authorized a post-marketing.

The manufacture and marketing of Azelnidipine and Metoprolol FDC tablets has been approved by the CDSCO Panel for Akum Pharmaceutical.

New Delhi: The Subject Expert Committee (SEC) operating under the Central Drug Standard has given the go-ahead to the pharmaceutical giant Akum Pharmaceuticals.

A radiologist found guilty of violating the PC PNDT Act received a two-year rigorous prison sentence.

A session court in Jabalpur has found a DMRD doctor guilty of a heinous violation of the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act.

The deadline to submit course preferences, willingness to work, and fee for the special straw vacancy round for PG medical seats in Puducherry is today.

The Centralized Admission Committee (CENTAC) in Puducherry has released a notification concerning the special stray vacancy round for three open NEET PG seats.

Check Your Information: Media reports asserting that biology is not necessary for NEET UG are false.

New Delhi: Posts on social media assert that biology coursework is no longer necessary for applicants to the National Exam to pursue careers in medicine.

The MP government issues a directive to Yatharth Hospital to assume control of the Ramraja Hospital grounds.

MP: As a result of an order from the Commissionerate of Sagar Sambhag, Madhya, Yatharth Hospital experienced significant trouble yesterday.

Health Bulletin / November 30, 2023.

Following a spike in respiratory cases, Uttarakhand and Karnataka are on alert due to a pneumonia outbreak in China. These are the top health stories of the day.

No Medical Negligence: Kerala High Court Rejects Payment to Patient Who Delivered Fifth Child Despite Post-Partum Sterilization.

In Ernakulam, a 39-year-old woman who underwent family planning was denied compensation after becoming pregnant and giving birth to her fifth child.

When open-angle glaucoma is first diagnosed, abstinence from alcohol lessens the severity of vision impairment.

High intraocular pressure and a greater incidence of open-angle glaucoma (OAG) have been associated with alcohol consumption. More research is still needed.

When compared to standard strategies, the use of MRI-guided biopsy for prostate cancer surveillance is more cost-effective.

Compared to conventional methods, MRI use and possibly MRI-guided biopsy are more affordable for prostate cancer surveillance.

Provide Justification for Research on Tocilizumab in Patients with Giant Cell Arteritis: Cipla Hears from the CDSCO Panel.

Examining the procedure that the pharmaceutical company Cipla submitted for the approval of post-marketing active surveillance of tocilizumab in patients in New Delhi.

A study found that steroid therapy combined with hyperbaric oxygen therapy was effective for individuals experiencing sudden hearing loss.

Japan: A recent study that was published in Otology and Neurotology found that using hyperbaric oxygen therapy in conjunction with other treatments improved recovery rates.

Which is better for treating pain following surgery in young patients: NSAIDs or opioids?

USA: To find out, a recent study compared two treatment plans: one that included a low-dose opioid addition and the other that used a regimen of non-opioid medication.

Recommended News For You

New tumor therapy approach reduces costs and side effects while increasing accessibility

Squeezing through tiny blood vessels may trigger melanoma cells to spread

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

Drug-chemo combo increases cancer treatment efficacy

Having a tattoo could increase your risk of developing lymphoma.

After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

Recommended Articles For You

The Power of White Blood Cells: How They Help Keep Us Healthy 

Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA 

Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study 

New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parkinson patient's gait is restored by a spinal cord stimulator.

2.

A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.

3.

Next Day Mood Is Affected by Ability to Recover From Work.

4.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

5.

Children with cancer experience much less pain at home when using a pain monitoring app.

1.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

2.

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology

3.

New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma 

4.

The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects 

5.

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

2.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

3.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

4.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot